Global Benign Prostatic Hyperplasia Devices Market by Procedure Types, End-users, Regions, Market Size, Share and Trends, Forecast 2020–2026

Global Benign Prostatic Hyperplasia Devices Market is valued to grow at a healthy CAGR of 8.45% over the forecast period 2020–2026. Rising geriatric population, growing prevalence of BPH diseases and their treatment, increased awareness for prostate cancer and other urological disorders are the factors driving the market growth.

Get Sample Report: https://dataintelo.com/request-sample/?reportId=6813

The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years.

Market Trends, Drivers, Restraints, and Opportunities:

Constant technologic improvements have led to the expansion of benign prostatic hyperplasia (BPH) devices with greater safety and quality.
To treat lower urinary tract symptoms (LUTS) related with BPH and minimize the side effects and sexual dysfunction, numerous novel technologies are being developed and launched.
Evolving therapies help lessen hospitalization, recovery time, and the need of general anesthesia during the treatment and to manage post-operative pain. This, in turn, is anticipated to fuel market growth.
Some of the recently permitted therapies for BPH consist of radio-frequency (RF), water vapor thermal therapy (Rezum System), and PUL (UroLift System). Development of such technologies is expected to significantly drive the benign prostatic hyperplasia devices market in the coming years.
Factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases are likely to hinder the growth of the market.
Technological advancements are boosting the growth of minimally invasive BPH procedures by improving their efficacy and safety. Numerous new minimally invasive treatment modalities have been developed as probable substitutes to traditional open operations and gold standard invasive that entailed extended recovery time and lengthy hospital stays.